Virological efficacy in HIV-infected patients affected by non-Hodgkin lymphoma, treated with antiblastic chemotherapy and highly active antiretroviral therapy.

doi:10.1080/03008870310009678

Article

Virological efficacy in HIV-infected patients affected by non-Hodgkin lymphoma, treated with antiblastic chemotherapy and highly active antiretroviral therapy.

Scandinavian journal of infectious diseases. Supplementum - 1 Jan 2003

Simonelli Cecilia, Zanussi Stefania, Cinelli Roberta, Dal Maso Luigino, Di Gennaro Giampiero, D'Andrea Monica, Nasti Guglielmo, Spina Michele, Vaccher Emanuela, De Paoli Paolo, Tirelli Umberto

Abstract excerpt

This study evaluated replication of human immunodeficiency virus (HIV) and the genotypic resistance pattern in 26 HIV-infected patients affected by non-Hodgkin lymphoma who were treated with at least 3 cycles of chemotherapy (CT; rituximab and CDE) and highly active antiretroviral therapy (HAART). Genotyping was performed at baseline and when virological failure occurred. Six patients met the virological failure...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Virological efficacy in HIV-infected patients affected by non-Hodgkin lymphoma, treated with antiblastic chemotherapy and highly active antiretroviral therapy.

Abstract excerpt

Topics

Related research